Reported disclosures lacking among patient-advocacy groups

Researchers at the University of Pennsylvania’s Perelman School of Medicine found that many patient-advocacy organizations do not adequately disclose funding or other connections with drug of medical device makers, according to recent findings.“What we’re seeing is that institutional conflicts of interest are the norm among larger patient-advocacy organizations, and that disclosures and management of these conflicts [are] limited,” Harald Schmidt, PhD, assistant professor of medical ethics and health policy at the University of Pennsylvania’s Perlman School of Medicine, said in the release.

Full Story →